Neurological Institute Outcomes
Epilepsy
Adult Epilepsy: Effect of Treatment on Quality of Life
2007 - 2021
Improvement in Quality of Life in Medically Treated Adult Epilepsy Patients (N = 3664)
2007 – 2021
QOLIE-10 = Quality of Life in Epilepsy questionnaire
In medically treated patients, the mean QOLIE-10 score improved from 21.8 at initial visit to 20.9 at last follow-up (P < 0.001). The median (Q1, Q2) was 20 (15, 28) at initial visit and 20 (15, 25) at follow-up.
N = patients with at least 6 months of follow-up.
Mean duration of follow-up was 67.1 months.
The standard box plots reflect the median and the 25th and 75th quartiles.
Improvement in Quality of Life in Surgically Treated Adult Epilepsy Patients (N = 599)
2007 – 2021
QOLIE-10 = Quality of Life in Epilepsy questionnaire
In surgically treated patients, the mean QOLIE-10 score improved from 27.8 at initial visit to 23.1 at last follow-up (P < 0.001). The median (Q1, Q2) was 27 (21, 35) at initial visit and 22 (17, 29) at follow-up.
N = patients with at least 6 months of follow-up.
Mean duration of follow-up was 44.3 months.
The standard box plots reflect the median and the 25th and 75th quartiles.
Clinically Meaningful Improvement in Quality of Life
2007 – 2021
| Patients Achieving Clinically Meaningful Improvement | |
|---|---|
| Medically treated patients (N = 3664) | 39.9% |
| Surgically treated patients (N = 599) | 56.7% |
Clinically meaningful improvement in quality of life is defined as a drop of at least 10% in the baseline QOLIE-10 Score.¹
